Literature DB >> 32335754

Association of osteosarcopenic obesity and its components: osteoporosis, sarcopenia and obesity with insulin resistance.

Kayoung Lee1.   

Abstract

INTRODUCTION: To evaluate the differences in the associations of combinations of co-existent osteopenia, obesity, and/or sarcopenia with insulin resistance (IR) according to different criteria of obesity.
MATERIALS AND METHODS: Among 4500 Korean men and postmenopausal women who were aged ≥ 50 years and did not have diabetes mellitus, osteopenia, sarcopenia, and obesity were defined using bone mineral density, skeletal mass index, and body fat % (or BMI). Body composition groups were generated based on the combinations of these components. IR was defined using the HOMA-IR ≥ 2.5.
RESULTS: When obesity was defined by body fat % and the relationships were adjusted for age, sex, education, and health behaviors, the odds ratios (ORs) for IR was highest in the groups with obesity and osteopenic obesity, followed by sarcopenic obesity and osteosarcopenic obesity, followed by osteopenia and sarcopenia, and followed by osteosarcopenia. When BMI was additionally adjusted, the ORs for IR were not significantly different between body composition groups except for osteopenia: those groups had higher ORs for IR compared to osteopenia. When obesity was defined by BMI, obesity co-existent groups had higher ORs for IR than the obesity non-coexistent groups. The ORs for IR were not significantly different within obesity co-existent groups or obesity non-coexistent groups.
CONCLUSIONS: Combinations of co-existent osteopenia, obesity, and/or sarcopenia had different associations with IR according to obesity classification methods and consideration of BMI adjustment. Osteosarcopenic obesity may not have a stronger association with IR compared to obesity only and obesity co-existent other conditions.

Entities:  

Keywords:  Insulin resistance; Osteopenic obesity; Osteosarcopenia; Osteosarcopenic obesity; Sarcopenic obesity

Mesh:

Year:  2020        PMID: 32335754     DOI: 10.1007/s00774-020-01104-2

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  2 in total

1.  Early Lifestyle Intervention for Obesity Prevention in Pediatric Survivors of Acute Lymphoblastic Leukemia.

Authors:  Fang Fang Zhang; Michael Kelly; Mengxi Du; Jennifer G Welch; Nadine Santacruz; Jacqueline Rhoades; Christina Luongo Kamins; ZoAnn Dreyer; Michael E Scheurer
Journal:  Nutrients       Date:  2019-11-02       Impact factor: 5.717

  2 in total
  5 in total

Review 1.  Vitamin D in Osteosarcopenic Obesity.

Authors:  Luigi Di Filippo; Rebecca De Lorenzo; Andrea Giustina; Patrizia Rovere-Querini; Caterina Conte
Journal:  Nutrients       Date:  2022-04-26       Impact factor: 6.706

2.  The Association Between Sarcopenic Obesity and Hypertension, Diabetes, and Abnormal Lipid Metabolism in Chinese Adults.

Authors:  Ting Yin; Jia-Xing Zhang; Fa-Xuan Wang; Jian-Hua Zhao; Yu Zhao; Lan Liu; Xiu-Ying Liu; Yu-Hong Zhang; Yi Zhao
Journal:  Diabetes Metab Syndr Obes       Date:  2021-04-30       Impact factor: 3.168

3.  Coexistence of osteoporosis, sarcopenia and obesity in community-dwelling adults - The Yishun Study.

Authors:  Benedict Wei Jun Pang; Shiou-Liang Wee; Kenneth Kexun Chen; Lay Khoon Lau; Khalid Abdul Jabbar; Wei Ting Seah; Daniella Hui Min Ng; Queenie Lin Ling Tan; Mallya Ullal Jagadish; Tze Pin Ng
Journal:  Osteoporos Sarcopenia       Date:  2021-01-07

4.  Association between biomarkers of bone health and osteosarcopenia among Iranian older people: The Bushehr Elderly Health (BEH) program.

Authors:  Maryam Fathi; Ramin Heshmat; Mehdi Ebrahimi; Ahmad Salimzadeh; Afshin Ostovar; Ali Fathi; Farideh Razi; Iraj Nabipour; Maryam Moghaddassi; Gita Shafiee
Journal:  BMC Geriatr       Date:  2021-11-19       Impact factor: 3.921

Review 5.  Relationship Between Sarcopenia and Cardiovascular Diseases in the Elderly: An Overview.

Authors:  Nana He; Yuelin Zhang; Lu Zhang; Shun Zhang; Honghua Ye
Journal:  Front Cardiovasc Med       Date:  2021-12-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.